Avivagen Inc.
VIVXF
$0.00
$0.000.00%
OTC PK
| 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -699.30K | -919.10K | -856.10K | -983.00K | -1.48M |
| Total Depreciation and Amortization | 4.00K | 11.30K | 15.10K | 15.30K | 15.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 387.70K | 454.60K | 258.80K | 482.30K | 356.50K |
| Change in Net Operating Assets | 361.20K | 495.50K | 485.50K | -64.90K | 217.20K |
| Cash from Operations | 53.60K | 42.40K | -96.70K | -550.30K | -888.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | -4.46M |
| Total Debt Repaid | 9.20K | -23.40K | -22.90K | -12.90K | -549.70K |
| Issuance of Common Stock | 0.00 | 29.50K | -- | 605.00K | 3.78M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -80.40K | -73.30K | -110.90K | -63.30K | 1.39M |
| Cash from Financing | -53.40K | -49.60K | -99.20K | 397.30K | 130.70K |
| Foreign Exchange rate Adjustments | -200.00 | 200.00 | 200.00 | -600.00 | 3.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | -7.00K | -195.70K | -153.50K | -754.40K |